{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:19:35Z","timestamp":1787019575817,"version":"build-2736575974"},"reference-count":28,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,11,26]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Ecto+ ILC neutralize extracellular ATP and suppress autologous T cells via the production of adenosine. Human acute GVHD is associated with a depletion of tissue ecto+ ILC3 and a reduction in serum adenosine levels.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000176","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T11:38:21Z","timestamp":1574336301000},"page":"3650-3660","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":34,"title":["Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease"],"prefix":"10.1182","volume":"3","author":[{"given":"Mette D.","family":"Hazenberg","sequence":"first","affiliation":[{"name":"Department of Hematology,"},{"name":"Amsterdam Infection & Immunity Institute,"},{"name":"Cancer Center Amsterdam,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke J. E.","family":"Haverkate","sequence":"additional","affiliation":[{"name":"Department of Hematology,"},{"name":"Amsterdam Infection & Immunity Institute,"},{"name":"Cancer Center Amsterdam,"},{"name":"Department of Experimental Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannouck F.","family":"van Lier","sequence":"additional","affiliation":[{"name":"Department of Hematology,"},{"name":"Amsterdam Infection & Immunity Institute,"},{"name":"Cancer Center Amsterdam,"},{"name":"Department of Experimental Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hergen","family":"Spits","sequence":"additional","affiliation":[{"name":"Amsterdam Infection & Immunity Institute,"},{"name":"Cancer Center Amsterdam,"},{"name":"Department of Experimental Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-8376","authenticated-orcid":false,"given":"Lisette","family":"Krabbendam","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Bemelman","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Amsterdam University Medical Center (UMC), location Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne J.","family":"Buskens","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Amsterdam University Medical Center (UMC), location Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Blom","sequence":"additional","affiliation":[{"name":"Amsterdam Infection & Immunity Institute,"},{"name":"Cancer Center Amsterdam,"},{"name":"Department of Experimental Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medya M.","family":"Shikhagaie","sequence":"additional","affiliation":[{"name":"Department of Hematology,"},{"name":"Amsterdam Infection & Immunity Institute,"},{"name":"Cancer Center Amsterdam,"},{"name":"Department of Experimental Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"issue":"4","key":"2019112111381799700_B1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11302-014-9427-2","article-title":"Purinergic signalling and immune cells","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal"},{"issue":"6","key":"2019112111381799700_B2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol Med"},{"issue":"1","key":"2019112111381799700_B3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol Rev"},{"issue":"2","key":"2019112111381799700_B4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4049\/jimmunol.164.2.1013","article-title":"Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock","volume":"164","author":"Hask\u00f3","year":"2000","journal-title":"J Immunol"},{"issue":"19","key":"2019112111381799700_B5","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood-2011-09-375899","article-title":"Deficiency of CD73\/ecto-5\u2032-nucleotidase in mice enhances acute graft-versus-host disease","volume":"119","author":"Tsukamoto","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019112111381799700_B6","doi-asserted-by":"crossref","first-page":"e22107","DOI":"10.4161\/onci.22107","article-title":"A delicate balance: CD73-generated adenosine limits the severity of graft vs. host disease but also constrains the allogeneic graft vs. tumor effect","volume":"2","author":"Thompson","year":"2013","journal-title":"OncoImmunology"},{"issue":"9","key":"2019112111381799700_B7","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/leu.2016.87","article-title":"The NOTCH1\/CD39 axis: a Treg trip-switch for GvHD","volume":"30","author":"Del Papa","year":"2016","journal-title":"Leukemia"},{"issue":"12","key":"2019112111381799700_B8","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/nm.2242","article-title":"Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R","volume":"16","author":"Wilhelm","year":"2010","journal-title":"Nat Med"},{"issue":"1","key":"2019112111381799700_B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood-2016-10-735696","article-title":"Introduction to a review series on chronic GVHD: from pathogenic B-cell receptor signaling to novel therapeutic targets","volume":"129","author":"Zeiser","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2019112111381799700_B10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1189\/jlb.0609388","article-title":"Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation","volume":"87","author":"Lappas","year":"2010","journal-title":"J Leukoc Biol"},{"issue":"5","key":"2019112111381799700_B11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"6238","key":"2019112111381799700_B12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.aaa4812","article-title":"Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells","volume":"348","author":"Hepworth","year":"2015","journal-title":"Science"},{"issue":"7452","key":"2019112111381799700_B13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature12240","article-title":"Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria","volume":"498","author":"Hepworth","year":"2013","journal-title":"Nature"},{"issue":"2","key":"2019112111381799700_B14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.immuni.2013.08.002","article-title":"Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora","volume":"39","author":"Qiu","year":"2013","journal-title":"Immunity"},{"key":"2019112111381799700_B15","first-page":"201","article-title":"Regulatory innate lymphoid cells control innate intestinal inflammation","volume-title":"Cell","author":"Wang","year":"2017"},{"issue":"6","key":"2019112111381799700_B16","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.jaci.2018.12.1018","article-title":"Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid","volume":"143","author":"Morita","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2019112111381799700_B17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease","volume":"37","author":"Hanash","year":"2012","journal-title":"Immunity"},{"issue":"5","key":"2019112111381799700_B18","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1172\/JCI91816","article-title":"Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease","volume":"127","author":"Bruce","year":"2017","journal-title":"J Clin Invest"},{"issue":"5","key":"2019112111381799700_B19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2013-11-536888","article-title":"Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease","volume":"124","author":"Munneke","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2019112111381799700_B20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/clinchem\/46.4.445","article-title":"Rapid screening of high-risk patients for disorders of purine and pyrimidine metabolism using HPLC-electrospray tandem mass spectrometry of liquid urine or urine-soaked filter paper strips","volume":"46","author":"Ito","year":"2000","journal-title":"Clin Chem"},{"issue":"1","key":"2019112111381799700_B21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.immuni.2016.11.005","article-title":"Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency [published correction appears in Immunity. 2018;48(5):1060]","volume":"46","author":"Simoni","year":"2017","journal-title":"Immunity"},{"key":"2019112111381799700_B22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-385526-8.00010-2","article-title":"Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity","volume":"61","author":"Deaglio","year":"2011","journal-title":"Adv Pharmacol"},{"issue":"7","key":"2019112111381799700_B23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1182\/bloodadvances.2018027474","article-title":"Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease","volume":"3","author":"Whangbo","year":"2019","journal-title":"Blood Adv"},{"issue":"2","key":"2019112111381799700_B24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1182\/blood-2007-09-111203","article-title":"Hydrolysis of extracellular ATP and immune suppression: humans versus mice","volume":"111","author":"Gorini","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019112111381799700_B25","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.4049\/jimmunol.1103800","article-title":"Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation","volume":"189","author":"Trabanelli","year":"2012","journal-title":"J Immunol"},{"issue":"7","key":"2019112111381799700_B26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.it.2016.04.009","article-title":"Regulation of the T cell response by CD39","volume":"37","author":"Takenaka","year":"2016","journal-title":"Trends Immunol"},{"issue":"39","key":"2019112111381799700_B27","doi-asserted-by":"crossref","first-page":"16788","DOI":"10.1073\/pnas.0902869106","article-title":"From the cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease","volume":"106","author":"Friedman","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019112111381799700_B28","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/imcb.12167","article-title":"Purine metabolism controls innate lymphoid cell function and protects against intestinal injury","volume":"96","author":"Crittenden","year":"2018","journal-title":"Immunol Cell Biol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/22\/3650\/1542505\/advancesadv2019000176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/22\/3650\/1542505\/advancesadv2019000176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T16:54:18Z","timestamp":1612457658000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/22\/3650\/428818\/Human-ectoenzymeexpressing-ILC3-immunosuppressive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":28,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,11,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000176","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]}}}